Shares of WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY – Get Free Report) saw an uptick in trading volume on Monday . 10,262 shares were traded during mid-day trading, an increase of 348% from the previous session’s volume of 2,290 shares.The stock last traded at $25.50 and had previously closed at $26.17.
Analyst Ratings Changes
Separately, Zacks Research raised shares of WuXi AppTec from a “hold” rating to a “strong-buy” rating in a report on Friday, August 7th. One research analyst has rated the stock with a Strong Buy rating and one has assigned a Buy rating to the stock. According to MarketBeat, the company has an average rating of “Strong Buy”.
Check Out Our Latest Stock Analysis on WUXAY
WuXi AppTec Stock Up 3.1%
WuXi AppTec Company Profile
WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.
Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.
Further Reading
- Five stocks we like better than WuXi AppTec
- Tariffs Are Back in Focus: 3 Stocks With a Home-Field Advantage
- Marzetti Stock Confirms Reversal on Earnings Strength, Dividend Growth
- Pathward’s Credit Scare Tests Its Comeback Story
- Wiring the AI Boom: Rumble’s $13.7B Pivot
Receive News & Ratings for WuXi AppTec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi AppTec and related companies with MarketBeat.com's FREE daily email newsletter.
